Analysis the Situation of Domestic and Foreign Pharmacoeconomics Research by Using CiteSpace Software
10.6039/j.issn.1001-0408.2018.11.25
- VernacularTitle:利用CiteSpace软件分析国内外药物经济学的研究现状
- Author:
Jing YUAN
1
;
Shaoliang TANG
Author Information
1. 南京中医药大学卫生经济管理学院
- Keywords:
Pharmacoeconomics;
CiteSpace software;
Subject;
Topic;
Citation;
Cluster
- From:
China Pharmacy
2018;29(11):1545-1550
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the research hotspots of pharmacoeconomics at home and abroad, and find out the shortcomings of pharmacoeconomics research in China. METHODS:Using"Pharmacoeconomice"as English subject and"pharmacoeconomics"as Chinese subject,SCI source journal,EI source journal,Chinese core journal and CSSCI literatures were retrieved from Web of Science core collection database and CNKI. The research hotspots and trend of pharmacoeconomics at home and abroad during Jan. 2007-Oct. 2017 were studied by using CiteSpace software in respects of subject analysis,topic analysis, citation analysis and keyword cluster analysis. RESULTS:A total of 912 English literatures and 486 Chinese literatures were included. Subject analysis showed that foreign researches on pharmacoeconomics focused on"pharmacology and pharmacy""health science and service",etc;domestic researches focused on"pharmacy""industrial economics",etc. Topic analysis showed that key words such as"quality of life"and"cost benefit analysis"appeared frequently in English literatures;key words such as"cost effectiveness analysis""pharmacoeconomic evaluation"appeared frequently in Chinese literatures. Citation analysis showed that the top 5 cited literatures in English literatures were mostly issued or put forward by related government departments or organizations' research reports;the top 5 cited literatures in Chinese literature were mostly research papers written by individuals. Cluster analysis showed that domestic pharmacoeconomics research mainly focused on drug price,drug policy and cost-effectiveness analysis of different drugs and treatment programs;compared with English literature,Chinese literature pharmacoeconomics still lacked in drug long-term safety,drug risk assessment and patient health. CONCLUSIONS:Domestic pharmacoeconomic researches are still focused on cost-effectiveness analysis of different treatment plans,but lack of research on residents'health care,quality adjustment life year compared with foreign researches. In addition,domestic pharmacoeconomic research were not enough,and research quality is in low level,which limits the application of pharmacoeconomics in China.
